Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

@article{Samo2016TicagrelorAS,
  title={Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?},
  author={Matej Samo{\vs} and Mari{\'a}n Fedor and Franti{\vs}ek Kov{\'a}ř and Luk{\'a}{\vs} Duraj and Lucia Stan{\vc}iakov{\'a} and Peter Galajda and J{\'a}n Sta{\vs}ko and Peter Kubisz and Mari{\'a}n Mok{\'a}ň},
  journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis},
  year={2016},
  volume={27 2},
  pages={117-20}
}
Stent thrombosis is a morbid complication following percutaneous coronary intervention (PCI). Dual antiplatelet therapy significantly reduces stent thrombosis risk. However, the antiplatelet response to clopidogrel - the most frequently used ADP receptor antagonist in post-PCI patients - varies among individuals. High on-treatment platelet reactivity was… CONTINUE READING